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Abstract
hsa-miR-191 is highly expressed in hepatocellular carcinoma (HCC), but the factors regulating this elevated expres-
sion are unknown. This study aimed to investigate the epigenetic mechanisms of increased hsa-miR-191 expres-
sion by analyzing the relationship between the DNA methylation status of hsa-miR-191 and miR-191 expression.
Methylation-specific polymerase chain reaction (PCR), bisulfite sequencing PCR, Northern blot, and quantitative
real-time PCR were performed to examine hsa-miR-191 methylation and expression levels. Western blot, transwell,
and scratch assays were performed to examine the function and molecular mechanisms of hsa-miR-191. Approx-
imately 58.9% of hsa-miR-191 expression was higher in HCC tissues than in adjacent noncancerous tissues; this
high expression was associated with poor prognosis. The hypomethylation observed in some HCC cell lines and
HCC tissues was correlated with the hsa-miR-191 expression level. This correlation was validated by treatment
with the 5-aza-DAC demethylation agent. The level of hypomethylation was 63.0% in 73 clinical HCC tissue sam-
ples and was associated with increased (2.1-fold) hsa-miR-191 expression. The elevated expression of hsa-miR-191
in the SMMC-771 HCC cell line induced the cells to transition into mesenchymal-like cells; they exhibited charac-
teristics such as loss of adhesion, down-regulation of epithelial cell markers, up-regulation of mesenchymal cell
markers, and increased cell migration and invasion. Inhibiting hsa-miR-191 expression in the SMMC-7721 cell line
reversed this process (as assessed by cell morphology and cell markers). Furthermore, hsa-miR-191 probably
exerted its function by directly targeting TIMP metallopeptidase inhibitor 3 and inhibiting TIMP3 protein expres-
sion. Our results suggest that hsa-miR-191 locus hypomethylation causes an increase in hsa-miR-191 expression
in HCC clinical tissues and that this expression induces HCC cells to transition into mesenchymal-like cells.
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Introduction
Hepatocellular carcinoma (HCC) is one of the most common hu-
man malignancies worldwide, with a particularly high prevalence
in East Asia and South Africa [1]. Although the risk factors for
HCC, which include hepatitis B and C virus infections, aflatoxin
B exposure, and heavy consumption of alcohol, are well documented,
its molecular pathogenesis remains poorly understood. In the past
two decades, there has been great progress in the identification of
candidate HCC-related protein-coding genes. By contrast, little is
known about the roles of functional noncoding sequences related
to HCC, particularly those of microRNAs (miRNAs).
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DNA methylation is a type of epigenetic modification. Aberrant
methylation, consisting of DNA hypomethylation and/or promoter
gene CpG hypermethylation, is implicated in the development of a
variety of solid tumors, including HCC [2]. Cirrhosis [3], chronic
hepatitis [4], and alcohol consumption can induce liver lesions [4].
Aberrant DNA methylation is associated with liver lesions, which
could induce HCC. Previous research that has focused on DNA
methylation as a biomarker for the DNA methylome (microarray-
based studies) has shown that there are differences in the levels of
DNA methylation in various liver lesions (normal liver, hepatitis, cir-
rhosis, and HCC). Therefore, evaluation of the status of DNA meth-
ylation could aid in diagnosing, determining the prognosis of, and
helping to predict the risk of carcinogenesis in HCC.
miRNAs are small, endogenous, noncoding RNAs that serve as
posttranscriptional regulators of gene expression [5]; they bind to
the 3′ untranslated regions (UTRs) of target mRNAs and either pre-
vent their translation or cause their degradation. Accumulating evi-
dence has shown that miRNAs have crucial functions in a number of
cellular and biologic processes [6]. The deregulation of miRNAs
plays an important role in a wide range of human diseases, including
cancers [7]. Several studies have demonstrated that various miRNAs
are deregulated in HCC tissue samples compared with noncancerous
liver tissue controls. Other research has focused on identifying the
factors that regulate the expression of miRNAs in hepatic carcino-
genesis; for example, DNA methylation or transcription factors could
regulate the expression of miR-1 [8] and miR-124/miR-203 [9]. The
most well-studied topics in determining the molecular mechanism of
miRNAs is research on cancer phenotype and miRNA targeting of
genes. The factors that regulate miRNA expression are not clear;
in particular, the role of DNA methylation, an epigenetic regulatory
factor that controls miRNA transcription, has not been clarified.
In this study, we sought to identify miRNAs that are regulated by
DNA methylation. We obtained a DNA methylome, miRNA pro-
file, and mRNA profile in normal liver tissue and six HCC cell lines.
We found a target miRNA, miR-191, and then validated the corre-
lation of DNA methylation and expression for 73 pairs of clinical
tissues from HCC patients.
Materials and Methods
Human Tissues
Human primary HCC and adjacent, noncancerous liver tissues
(3 cm from the tumor) were collected from the surgical specimen
archives of Guangxi Medical University, Guangxi Province, China.
One of the two normal liver tissue samples was collected from a per-
son who died because of an accident; the other was purchased from
Clontech (Palo Alto, CA). All human materials were obtained with
informed consent, and the institutional ethics review committee of the
Shanghai Cancer Institute approved the protocols used in this study.
Clinical information was collected from patients’ records; details are
listed in Table W4.
Cell Lines and 5-Aza-DAC Treatments
SMMC-7721, QGY-7703, PLC/PRF/5, BEL-7402, HepG2, and
Hep3B human HCC cancer cell lines were used. Cells were cultured
in Dulbecco modified Eagle medium/F-12 (1:1) medium supple-
mented with 10% bovine calf serum (PAA Laboratories, Dartmouth,
MA) and antibiotics (Gibco, Invitrogen, Carlsbad, CA). The hsa-
miR-191–overexpressing SMMC-7721 cell line and its control were
cultured on poly-L-lysine (0.1 mg/ml; Sigma-Aldrich, St Louis,
MO)–precoated plates. The QGY-7402 cell line was seeded at a den-
sity of 106 cells/10-cm dish, cultured for 48 hours, and treated with
freshly prepared 5 μM 5-Aza-CdR (Sigma-Aldrich) dissolved in 50%
acetic acid.
Transfections
MicroRNA mimics and miRNA antagomiRs were designed and
synthesized by RiboBio (Guangzhou China). The miRNA antagomiRs
were all nucleotides with a 2′-O-methyl modification. The miRNAmim-
ics were transiently transfected with Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s protocol. The miRNA antagomiRs
were transiently transfected with Amaxa Nucleofector (Amaxa, Koeln,
Germany) according to the manufacturer’s protocol.
DNA Preparation, RNA Extraction, and Quantitative
Real-time Polymerase Chain Reaction
Genomic DNA was isolated using the QIAamp DNA Mini Kit
(Qiagen, Valencia, CA) according to the manufacturer’s protocol.
Total RNA was isolated using TRIzol Reagent for Molecular Biology
(Invitrogen/Life Technologies). Genomic DNA from tumor samples
was purified by standard phenol/chloroform purification. DNA qual-
ity was verified by electrophoresis through an agarose gel and visual-
ized with ethidium bromide. For microarray experiments, total RNA
was further purified using the RNeasy Mini Kit (Qiagen). For quanti-
tative real-time polymerase chain reaction (qRT-PCR), 5 μg of total
RNA was previously treated with the RQ1 RNase-free DNase (Promega,
Madison, WI). The complementary DNA of genes was synthesized
using the TIANScript RT Kit (Tiangen, Beijing, China). The com-
plementary DNA from the miRNA was synthesized using the Quant
Reverse Transcriptase (Tiangen) and an reverse transcript primer from
RiboBio. Real-time PCR analyses were performed with Real MasterMix
(SYBR Green; Tiangen) using synthesized primers that were purchased
from RiboBio. The primers for the hsa-miR-191 host gene DALRD3
and its antisense gene NDUFAF3 were designed using the Web site
http://pga.mgh.harvard.edu/primerbank/:
DALRD3RTF: 5′ AGGCTGACAGCAGTATCTCCAC 3′
DALRD3RTR: 5′ GAGCAACAACCACTCACCCTC 3′
NDUFAF3RTF: 5′ GACATCACCGAAGACAGCTTT 3′
NDUFAF3RTR: 5′ CACCACCACGATCTCTATCCG 3′
Bisulfite Treatment and Methylation-Specific and
Bisulfite-Sequencing PCR Analyses
The bisulfite conversion and PCR analyses were performed as de-
scribed previously [10]. The primers involved in methylation-specific
(MSP) and bisulfite-sequencing PCRs (BSP) were designed using
the Web site (http://www.urogene.org/methprimer/index1.html).
To design the primers, the target sequence from the region with a
methylation signal in the DNA methylome was used, taking into
consideration the repeat sequence around the target sequence. The
following primers were used for the BSP assay: hsa-miR-191bspf,
5′ TGGTTGTTGTTTAAAATAGGAA 3′; and hsa-miR-191bspt,
5′ TACCTCAATCTCCCAAATAACT 3′. The following primers
were used for the MSP assay: Msp forward methylation primer, 5′
TTTAAAATAGGAAGTTTTAAGGATCGT 3′; Msp reverse meth-
ylation primer, 5′ AAATAACTAAAATTACAAACACGCG 3′; Msp
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forward nonmethylation primer, 5′ TTTAAAATAGGAAGTTT-
TAAGGATTGT 3′; and Msp reverse nonmethylation primer, 5′
ATAACTAAAATTACAAACACACACC 3′. The T m was 52°C,
and there were 35 PCR cycles.
Vector Constructs
A putative hsa-miR-191 binding site in the TIMP metallopep-
tidase inhibitor 3 (TIMP3) 3′UTR was inserted downstream of
a cytomegalovirus promoter-driven firefly luciferase cassette in a
pCDNA3.0 vector. The following oligos were used: TIMP3 Ecf, 5′
AATTGTTGCCTTAGGGTTTTCGTCGACT 3′; and TIMP3
Xbt, 5′ CTAGAGTCGACGAAAACCCTAAGGCAAC 3′. These
oligos annealed and were ligated to the vector.
Lentiviral Production and Transduction
Virus particles carrying the hsa-pri-miR-191 precursor and its
control were purchased from GENECHEM (Shanghai, China).
The lentiviral transduction was carried out according to advice from
GENECHEM. The resulting cells were seeded onto 96-well plates and
cultured for 2 months to produce a stable hsa-miR-191–overexpressing
cell line. The high expression was validated by qRT-PCR.
In Vitro Migration and Invasion Assays
The invasion assays were performed using the Neuro Probe Stan-
dard 12-well Chemotaxis Chamber (catalog no. AA12; Gaithersburg,
MD). The lower wells were filled with complete culture medium, and
the upper wells, which contained 5000 cells, were filled with medium
lacking serum. The porous polycarbonate membrane (8-μm pores) sep-
arating the two wells was coated with Matrigel (BD Biosciences).
Migration assays were performed by seeding cells onto a six-well
plate coated with fibronectin (Sigma-Aldrich). After the cells that
were attached to the plate reached 100% confluence, the confluent
monolayer was scratched using a sterile pipette tip. Photographs of
cell migration into the scratched area were taken, and statistical anal-
ysis was performed on five randomly chosen fields.
Northern and Western Blots
Northern blots were performed as reported previously [11]. The
optimized hybridization temperature for the probe against hsa-
miR-191 was 39°C. The following probes were used in the Northern
blot assay: hsa-miR-191, 5′ CAGCTGCTTTTGGGATTCCGTTG
3′; and U6, 5′ AACGCTTCACGAATTTGCGT 3′. Twenty micro-
grams of total RNA was loaded into each well.
Proteins were separated by SDS-PAGE and transferred to a poly
(vinylidene fluoride) membrane (Bio-Rad,Hercules, CA). Themembrane
was blocked with 5% nonfat milk and incubated with mouse anti–pan-
cytokeratin monoclonal antibody (1:1000), antiactin monoclonal anti-
body (1:2000; Santa Cruz Biotechnology, Santa Cruz, CA), rabbit
anti–E-cadherin (1:50),N-cadherin (1:50), TIMP3 (1:100), and vimentin
(1:500) polyclonal antibodies (Abgent, Inc, San Diego, CA).
The resulting RNA and protein bands were quantified using Image-
Quant Capture software (version 1.0.0; GE Healthcare Life Sciences,
Piscataway, NJ).
DNA Methylome, miRNA, and mRNA Expression Profiles
The DNA methylome was performed as reported previously
[12,13]. The miRNA and mRNA expression profiles were exerted by
BGI-Shenzhen (Shenzhen, Guangdong, China). The DNA meth-
ylome of normal liner tissue and HCC cell lines was aligned (shown
on the following UCSC Web site: http://genome.ucsc.edu/cgi-bin/
hgTracks?hgS_doOtherUser=submit&hgS_otherUserName=Zhujingde&
hgS_otherUserSessionName=LiverCancer_hg19). The other two
expression profiles are shown in Tables W2 and W3.
Statistical Analysis
Data are expressed as the mean ± SEM from at least three separate
experiments. The data were analyzed with either a two-tailed Stu-
dent’s t test/χ2 or a one-way analysis of variance for the comparison
of more than two groups unless otherwise specified; P < .05 was con-
sidered significant.
Accession Numbers
Hsa-miR-191: NR_029690.1
TIMP3: NM_000362.4.
Results
miRNA Expression in HCC Is Regulated by DNA Methylation
To identify the novel DNA methylation regulation of miRNAs
in HCC, we ascertained the miRNA expression profile and DNA
methylome in normal liver tissues and SMMC-7721, QGY-7703,
PLC/PRF/5, BEL-7402, HepG2, and Hep3B cell lines. First, we ob-
tained the locations for all of the miRNAs and CpG islands in the
chromosome. If there was a CpG island within 2000 base pairs (bp)
of a miRNA gene, that miRNA was chosen as a candidate for DNA
methylation regulation; this analysis identified 135 miRNAs. Sec-
ond, we eliminated the miRNAs that were not expressed (those that
had a read value <50) in the HCC cell lines or normal liver tissue
from our miRNA expression profile base, which left 31 miRNAs.
Third, we checked the DNA methylation status in our DNA meth-
ylome data. If there were no differences in DNA methylation be-
tween the normal liver tissue and HCC cell lines, the miRNA was
eliminated, which left us with 17 miRNAs. Finally, according to our
miRNA expression profile, hsa-miR-191 was found to be among the
13 most highly expressed miRNAs in HCC, and its expression level
was the highest of the 17 miRNAs in our final analysis. Therefore,
we chose miR-191 from the remaining 17 miRNAs (miR-191) for
further investigation (Figure 1A).
The DNA methylation statuses of 17 miRNAs in the DNA
methylome are shown in Figure 1B, and the expression levels of these
miRs were compared with normal liver tissue in the miRNA expres-
sion profile (Figure 1C ).
Relationship between miR-191 Expression in HCC Tissues and
Patient Outcomes
We analyzed 73 pairs of HCC clinical samples and found that the
miR-191 levels in the HCC tissues were upregulated by 37.2% com-
pared with adjacent noncancerous tissue. The rate of increased miR-
191 expression was 58.9%, and the miR-191 levels in both the HCC
tissues and adjacent noncancerous tissues were higher than that of
the normal liver tissue (Figure 2A).
We placed the samples into two categories based on their miR-191
expression levels in the HCC tissue. The 35 samples with lower ex-
pression levels were placed into the low-expression group, and the
35 samples with higher expression levels were placed into the high-
expression group. We evaluated the patient survival times after the
treatment; these are shown by the survival curve in Figure 2B. We
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found that the HCC patients with elevated miR-191 expression had
poor prognoses.
miR-191 is an intronic miRNA located in the intron of the
DALRD3 promoter; therefore, we analyzed the expression level of
the DALRD3 mRNA. We found that miR-191 tended to be coex-
pressed with DALRD3. This finding shows that the factors regulating
miR-191 expression act at least partially at the transcription level.
DALRD3, a miR-191 precursor, and NDUFAF3 are a cis-antisense
gene pair (Figure 2C1). These genes may be regulated by the same
factor (deletion and/or epigenetic modification, for example). We de-
termined the expression levels of these two genes and analyzed the
correlations between them and miR-191. We found that miR-191
tended to increase or decrease together with DALRD3 and NDUFAF3,
and the DALRD3 and NDUFAF3 expression levels were correlated
with each other (Figure 2, C2–C4 ).
These results show that the HCC tissues has high miR-191 expres-
sion and that patients with high miR-191 expression had poor progno-
ses. miR-191 tended to be coexpressed with the cis-antisense gene pair
DALRD3 andNDUFAF3, which implies that miR-191 expression may
be regulated by DNA deletion and/or epigenetic modification.
Hypomethylation in the First Intron of the hsa-miR-191
Host Gene DALRD3 and Increased hsa-miR-191
Expression in an HCC Cell Line
There is a CpG-rich sequence in the DALRD3 promoter, and the
DNA methylome data shows that a DNA methylation signal is located
Figure 1. MicroRNAs are regulated by DNA methylation. (A) Flowchart for the identification of miRNAs that may be regulated by DNA
methylation in normal liver tissue and HCC cell lines. The DNA and miRNA samples from normal liver tissue and HCC cells were col-
lected to construct DNA methylome and miRNA expression profiles. To compare the sites of miRNA and CpG islands on the chromo-
some, a set of 135 miRNAs was first used for analysis. Second, by eliminating the miRNAs that were not expressed in normal tissues or
HCC cell lines (based on our miRNA expression profile), we narrowed this set of miRNAs down to 31 miRNAs. Third, we analyzed the
differences in methylation signals from these 31 miRNAs between normal tissues and HCC cell lines, further narrowing the set of miRNAs
to 17. (B) Differences in DNA methylation between normal tissues and the HCC cell lines in the DNA methylome of 17 miRNAs. (C) Ex-
pression profiles of 17 miRNAs in HCC cell lines compared to normal liver tissue. The value shown here is the log (miRNA expression in the
HCC cell line/normal liver tissue); data are from miRNA expression profiles.
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in this region (Figure 3A). We determined the DNA methylation status
of this region using a BSP-based assay; the results indicated that there
are DNA methylation differences in the sense strands between the
PLC/PRF/5 and Hep3B from normal liver tissue and the SMMC-
7721, QGY-7703, BEL-7402, and HepG2 cell lines (Figure 3B).
The results indicate that the normal liver tissue and these six HCC cell
lines could be classified into two types. This region was hypermeth-
ylated in the normal liver tissue and in the SMMC-7721, QGY-
7703, HepG2, and BEL-7402 cell lines; by contrast, this region was
hypomethylated in the PLC/PRF/5 and Hep3B cell lines. No CpGs
were methylated in the other 2000-bp sequence that was examined
in the DALRD3 promoter (data not shown).
Next, Northern blot analysis was used to assess the hsa-miR-191
expression in the normal liver tissue and six HCC cell lines (Fig-
ure 3C ). hsa-miR-191 was highly expressed in the HCC cell lines,
especially PLC/PRF/5 and Hep3B (Figure 3C , lanes 4 and 7 ). In
addition, qRT-PCR revealed that the DALRD3 and NDUFAF3
mRNA levels were upregulated in PLC/PRF/5 and Hep3B compared
with the normal liver tissue and the other four cell lines (Figure 3, D
and E).
Together, the results of these assays showed that there was hypo-
methylation at the hsa-miR-191 locus and that its expression (and
the expression of its host gene) was correlated in the normal liver
tissue and six HCC cell lines.
DNA Methylation Status of the miR-191 Locus and
miR-191 Expression in BEL-7402 Cells after Treatment
with 5-Aza-CdR
To confirm the correlation between the hsa-miR-191 DNA methyl-
ation status and the hsa-miR-191 expression levels, we used BEL-7402
Figure 2. The high expression level of miR-191 in HCC tissues is associated with a poor prognosis. (A) We analyzed the expression levels
of miRNAs in 73 pairs of HCC tissues and found an increase of 37.2% in the expression level of miR-191 in HCC tissues when compared
with adjacent noncancerous tissues, P = .0066 (paired t test). miR-191 expression is upregulated in 58.9% of these 73 pairs of tissues.
The expression levels of miR-191 are higher in both HCC tissues and adjacent noncancerous tissues compared with normal tissues. (B)
Overexpression of miR-191 is associated with a poor prognosis. miR-191 expression in HCC tissues is listed from lowest to highest; the
35 HCC tissues with the lowest miR-191 expression levels were placed into the low-expression group, whereas the 35 HCC tissues with
the highest miR-191 expression levels were placed into the high-expression group. (C) The miR-191 precursors, DALRD3 and NDUFAF3,
a cis-antisense gene pair, tend to be coexpressed.
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Figure 3. Some cells show hypomethylation of the hsa-miR-191 locus and high expression of hsa-miR-191. (A) The miRNA hsa-miR-191
is located in the promoter region of DALRD3 on chromosome 3, where there is also a CpG-rich sequence and a DNA methylation signal.
In addition, BSP and MSP regions are located in the first intron of DALRD3, downstream of hsa-miR-191. (B) The hypomethylation of
hsa-miR-191 in HCC cells is shown by a BSP-based assay. The levels of DNA methylation are 92.9%, 82.9%, 84.3%, 12.9%, 85.7%,
92.9%, and 18.6% in normal liver tissue, SMMC-7721 cells, QGY-7703, PLC/PRF/5, BEL-7402, HepG2, and Hep3B cells, respectively. (C)
hsa-miR-191 expression levels in normal liver tissue and HCC cell lines by Northern blot. The quantification of hsa-miR-191 expression is
shown based on the results of a Northern blot assay. The expression level of hsa-miR-191 was normalized to that of U6. The expression
levels were upregulated 4.1-fold (P < .0001) and 3.21-fold (P < .0001) in PLC/PRF/5 and Hep3B cell lines, respectively, compared with
the levels of normal liver tissue. (D, E) mRNA levels of DALRD3 (D) and NDUFAF3 (E) in normal liver tissue and HCC cell lines were
analyzed by qRT-PCR. These two genes were highly expressed in PLC/PRF/5 and Hep3B cell lines. These results were analyzed by a
Student’s t test.
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as a model because the hsa-miR-191 locus is almost completely meth-
ylated and the expression level of hsa-miR-191 is low in these cells.
In the BEL-7402 cell line, the rate of DNA methylation decreased
from 84.3% to 71%, 51%, and 27% after 1-, 2-, and 5-day treat-
ments, respectively, with 5-aza-CdR (Figure 4A). The Northern
blot analysis and qRT-PCR assays revealed that the hsa-miR-191 ex-
pression in the 5-aza-CdR–treated BEL-7402 cells was upregulated
(Figure 4, B1 and B2) compared with the untreated controls. The
same results were seen in independent triplicate assays. We obtained
similar results for the SMMC-7721 cells (data not shown). In the
BEL-7402 cell line, the addition of trichostatin A (TSA), which specif-
ically inhibits mammalian histone deacetylase, 24 hours after the 5-day
5-aza-CdR treatment did not alter the hsa-miR-191 expression com-
pared with the expression levels of the trichostatin A–untreated con-
trols (data not shown). We also analyzed the DALRD3 and NDUFAF3
mRNA expression levels and found that these two genes were upregu-
lated after treatment (Figure 4, B2 or B3).
These results show that when 5-aza-CdR demethylates the se-
quence in the hsa-miR-191 locus, hsa-miR-191 and its host gene
are upregulated. Therefore, DNA methylation is able to regulate
hsa-miR-191 expression.
hsa-miR-191 Locus Methylation in HCC Primary Tumors and
Its Clinicopathologic Correlation
We analyzed hsa-miR-191 locus methylation in the 11 pairs of
HCC primary tumors; the results of this analysis are shown in
Figure 5A. All of the DNA was hypomethylated in these HCC sam-
ples and hypermethylated in their adjacent tissues. The miR-191 ex-
pression was correlated with methylation status in these samples
(Figure 5B).
Samples 257 and 202 were chosen to validate the DNA methyla-
tion status using the BSP-based assay. The results verified that there
was hypomethylation in the HCC samples and hypermethylation in
their adjacent tissues (Figure 5C ).
Next, we analyzed the 73 clinical HCC samples; the results of this
analysis are shown in Table W4, which shows that the hypomethyla-
tion rate was 63.0%. We placed these samples into two categories: a
hypomethylation group and a hypermethylation group. The miR-
191 expression levels in these two groups is shown in Figure 5D,
which indicates that the miR-191 expression was higher in the hy-
pomethylated group than in the hypermethylated group.
This result shows that the hypomethylation at the hsa-miR-191
locus was correlated with its expression in the clinical samples.
Overexpression of hsa-miR-191 Induces SMMC-7721 Cells to
Transition into Mesenchymal-like Cells
We examined the cell morphology, epithelial and mesenchymal
markers, and cell migration and invasion in stable hsa-miR-191–
overexpressing cells.
First, an SMMC-7721 cell line that stably overexpressed hsa-miR-191
was developed using a lentiviral-packed vector containing the hsa-miR-
191 precursor. By a qRT-PCR analysis, the two stably overexpressing
Figure 4. Alterations in DNA methylation status and hsa-miR-191 expression in BEL-7402 cells that were treated with 5′-aza-CdR. (A) The
hsa-miR-191 locus becomes hypomethylated after 5′-aza-CdR treatment. In BEL-7402 cells, the rate of DNA methylation before treatment
was 84.3% and decreased to 71%, 51%, 70%, and 27% after 1, 2, 3, and 5 days of treatment, respectively. (B) The levels of miR-191
expression (B1, B2) and the mRNA levels of DALRD3/NDUFAF3 (B3, B4) are upregulated after treatment with 5′-aza-CdR. The expression
level of miR-191 was detected by Northern blot and qRT-PCR, and the mRNA levels of DALRD3/NDUFAF3 were detected by qRT-PCR.
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Figure 5. The hsa-miR-191 locus is hypomethylated and highly expressed in HCC tissues. (A) An MSP-based assay was used to detect
hsa-miR-191 locus methylation in 11 pairs of clinical HCC tissues. No methylation of the hsa-miR-191 locus was observed in 11 HCC
tissues. (B) hsa-miR-191 is highly expressed in the 11 HCC tissues that were not methylated. (C) Validation of the MSP-based assay by
the BSP-based assay. Case nos. 257 and 202 were chosen for the assay. Hypermethylation was observed in adjacent noncancerous
tissues, and hypomethylation was observed in HCC tissues. (D) An MSP-based assay was used to detect methylation of the hsa-miR-191
locus in 73 clinical HCC tissues. On the basis of these results, the clinical tissues were placed into two categories, a methylated group
and a nonmethylated group. The expression level of hsa-miR-191 in the nonmethylated group was higher than the expression level in the
methylated group (2.1-fold difference). The rate of hypomethylation was 63.0%. The results were analyzed by a Student’s t test.
Figure 6. Overexpression of hsa-miR-191 induces SMMC-7721 cells to transition into mesenchymal-like cells. (A) Expression levels of
hsa-miR-191 in the hsa-miR-191 stably overexpressing cell line, as detected by qRT-PCR. The expression levels of hsa-miR-191 were
upregulated approximately four-fold in the two resultant clones. (B) Alterations in epithelial (cytokeratin and E-cadherin) and mesenchy-
mal (vimentin and N-cadherin) marker expression in the stable hsa-miR-191–overexpressing cell lines compared with the control. The
expression levels of the epithelial markers pan-cytokeratin and E-cadherin were sharply reduced. By contrast, the expression levels of
the mesenchymal markers vimentin and N-cadherin were increased in the hsa-miR-191–overexpressing cell lines. (C) The overexpres-
sion of hsa-miR-191 leads to an increase in cell migration. As determined by the scratch assay, the hsa-miR-191–overexpressing cell
lines reached 87% fusion 8 days after the scratch-induced wound compared with the control (stable overexpression of the empty vec-
tor; P = .0141 and P = .0045 in the stable hsa-miR-191–overexpressing cell lines 1 and 2, respectively). By contrast, the SMMC-7721
control cell line reached 59.0% fusion. (D) Morphology of the stable hsa-miR-191–overexpressing cell line compared with the morphol-
ogy of the control cell line. The overexpressing cells have long, thin processes and reduced cell-to-cell contacts. (E and F) Overexpres-
sion of hsa-miR-191 increased cell invasion as determined by the transwell assay using a Matrigel-coated membrane. Cell invasion
increased by 2.02-fold (P = .0028) and 1.72-fold (P = .0045) in the stable hsa-miR-191 overexpressing cell lines 1 and 2, respectively,
compared with the control. Results were analyzed by a Student’s t test.
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cell lines were shown to have a four-fold up-regulation of hsa-miR-191
expression (Figure 6A). The cell morphology of the stable cell line
was significantly altered (Figure 6D); the cells had long and thin pro-
cesses, cell-to-cell contraction was reduced, and their adhesion to the
plate was reduced; therefore, we cultured the cell line on poly-L-lysine–
precoated plates.
Next, the epithelial and mesenchymal cell marker expression levels
were examined in the stable cell lines and in the control cell line by
Western blot. In the stable hsa-miR-191–overexpressing cell lines, the
epithelial cell markers pan-cytokeratin and E-cadherin were sup-
pressed, and the mesenchymal cell markers vimentin and N-cadherin
were upregulated (Figure 6B).
To further evaluate hsa-miR-191 function in the liver cells, the effect
of stable hsa-miR-191 overexpression on the invasion and migration of
the SMMC-7721 cells was studied. The invasion assay revealed that
the cell invasion capacity of the stable hsa-miR-191–overexpressing
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cell lines was increased by more than 60% (Figure 6, E and F), and
the wound healing assay revealed that the migration capacity of these
cells was also increased (Figure 6C).
Inhibition of hsa-miR-191 Induces SMMC-7721 Cells to
Transition to Epithelial-Like Cells
We transiently transfected antagomiR to miR-191 into the SMMC-
7721 cell line with Amaxa Nucleofector, with a transfection efficiency
of 100% (using cotransfection with GFP as an indicator). The miR-
191 level was detected by qRT-PCR to confirm the efficiency of the
antagomiR, and it was significantly downregulated (Figure 7A).
The epithelial and mesenchymal cell marker expression levels were
then examined by Western blot assay in the SMMC-7721 cells that
were transfected with antagomiR to miR-191 or to NC. In the
SMMC-771 cells that were transfected with antagomiR to miR-191,
the pan-cytokeratin epithelial cell marker was upregulated compared
with the SMMC-7721 transfected with antagomiR to NC; conversely,
the level of the mesenchymal cell marker vimentin was reduced
(Figure 7B).
The cell morphology of the SMMC-7721 cells that were trans-
fected to miR-191 was significantly altered (Figure 7C ), and the
cell-to-cell contraction was increased (Figure 7C ).
Taken together, these in vitro results indicate that the hsa-miR-191
stable SMMC-7721 cell line had mesenchymal features, including
long and thin processes, loss of adhesion, reduced cell-to-cell contrac-
tion, and increased cell migration and invasion. In addition, inhibiting
the miR-191 expression in the SMMC-7721 cell line resulted in epi-
thelial features, including altered marker expression and increased cell-
to-cell contraction.
hsa-miR-191 Directly Suppresses TIMP3 Expression
Identifying the hsa-miR-191 target genes is essential to better un-
derstand its biologic functions. First, we obtained a prediction collec-
tion from miRNA.org. Second, we obtained two collections from our
mRNA microarray data: one that was highly expressed in normal tis-
sue, with low expression levels in PLC/PRF/5; and one that was
highly expressed in the SMMC-7721 cell line and had low expression
levels in PLC/PRF/5. Third, we compared these data to the data ob-
tained from miRNA.org; the common genes from these two sources
represented the target genes (Figure 8A).
According to their mRNA expression profiles (Figure 8B), TIMP3,
AUTS2 (autism susceptibility candidate 2), LTBP1 (latent transform-
ing growth factor beta-binding protein 1), PLOD2 (procollagen-lysine,
2-oxoglutarate 5-dioxygenase 2), LIMCH1 (LIM and calponin homol-
ogy domains 1), NFIA (nuclear factor I/A), BASP1 (brain abundant,
membrane attached signal protein 1), PCSK9 (proprotein convertase
subtilisin/kexin type 9), and SORL1 (sortilin-related receptor, L [DLR
class] A repeat containing) were candidates for the miR-191 targets. We
analyzed one of these candidates: TIMP3. The TIMP3 mRNA level in
the normal tissue and six cell lines is shown in Figure 8C ; the PLC/
PRF/5 and Hep3B cell lines had the lowest TIMP3 mRNA expression
levels. We placed the predicted miR-191 target sequence (Figure W1)
Figure 7. Inhibition of hsa-miR-191 induces SMMC-7721 cells to transition into epithelial-like cells. (A) Expression levels of hsa-miR-191
in the SMMC-7721 cell line transfected with antagomiR to miR-191, as detected by qRT-PCR. Expression levels of hsa-miR-191 were down-
regulated (P = .0026, P = .0016, and P = .0006 in the SMMC-7721 cells transfected with antagomiR to miR-191 [40, 120, and 360 pmol,
respectively] compared with their NC controls, Student’s t test). (B) Alterations in epithelial (cytokeratin) and mesenchymal (vimentin)
marker expression in the SMMC-7721 cells transfected with antagomiR-191 compared with the controls. The expression level of the
pan-cytokeratin epithelial marker was increased. By contrast, the expression level of the mesenchymal marker vimentin was suppressed.
(C) The morphology of the SMMC-7721 cells that were transfected with antagomiR to miR-191 is altered. The cell-to-cell contraction is
increased in the SMMC-7721 cells that were transfected with antagomiR to miR-191 compared with the controls.
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into the 3′UTR of luciferase, and the luciferase activity was downregu-
lated when the miR-191 mimics were cotransfected (Figure 8D). We
then checked the TIMP3 protein levels in the stable SMMC-7721 cell
lines, which indicated that miR-191 could induce decreased expression
of the TIMP3 protein (Figure 8E).
Together, these results show that hsa-miR-191 can target TIMP3
mRNA and suppress TIMP3 protein expression.
Discussion
The emergence of next-generation sequencing of bisulfite-converted
DNA represents an important advance in the field of DNA methyla-
tion analysis [12–16]. This technology has enabled human methylome
analysis to advance from single chromosomes [17] to low- (100-bp)
resolution complete genomes to single-base resolution complete ge-
nomes [18]. Using this technology, we obtained the DNA methylomes
of normal liver tissue and HCC cell lines to analyze the DNA meth-
ylation status in HCC more carefully. In our study, we found that 13
CpG-rich regions may regulate 17 miRNAs. Only seven miRs have
been reported in oncology research to be upregulated by DNA meth-
ylation; one of these seven miRs, miR-148a, has been reported to
be regulated by DNA methylation in HCC. We found that miR-
193a regulation by DNA methylation in HCC (unpublished data)
can be validated by these data, and we investigated other miRNAs
in this manner.
miRNA expression can be regulated at the level of expression or
splicing [19]. At the transcriptional level, the factors that regulate gene
expression are transcription factors, DNA deletion, and epigenetic
mechanisms. However, the gene structure of miR-191 is a special
cis-antisense gene structural pair. Gene transcription in this structure
may be regulated by DNA deletion or by epigenetic mechanisms [20].
Figure 8. Analysis of hsa-miR-191 targets. (A) Flowchart of hsa-miR-191 target analysis. The target analysis is based on the miR-191
expression level in HCC cell lines (Figure 2), mRNA expression profile (our unpublished data), and target prediction in microRNA.org.
Nine genes were chosen as putative miR-191 targets. (B) mRNA profiles of the nine target genes in the HCC cell lines. The value is the
log (mRNA expression in HCC cell line/normal liver tissue) according to the mRNA expression profile. (C) TIMP3 has low expression in
the HCC cell lines. TIMP3 has especially low expression in the PLC/PRF/5 and Hep3B cell lines. (D) Reduced firefly luciferase activity
owing to hsa-miR-191 expression. SMMC-7721 was cotransfected with hsa-miR-191 mimics and a reporter construct that carried a miR-
191 prediction target sequence in TIMP3; the activity of firefly luciferase was normalized to that of Renilla luciferase. Compared with the
control, the activity of firefly luciferase was reduced by 50% when the level of hsa-miR-191 was increased to 10 pmol/well (96-well
plate). (E) Reduction in TIMP3 protein levels in stable hsa-miR-191–overexpressing cell lines. Compared with the control, TIMP3 levels
were reduced by 50% to 80% in both stable hsa-miR-191–overexpressing cell lines.
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In our study, we found that elevated miR-191 expression was associ-
ated with hypomethylation at the miR-191 locus, both in the HCC
cell lines and clinical samples. The 5-aza-DAC demethylation agent
induced miR-191 locus demethylation and upregulated the expression
levels of miR-191 and its host gene. According to our data, the corre-
lation between the expression of miR-191 and that of its host gene
(DALRD3) is not perfect because the miR-191 and DALRD3 ex-
pression may be regulated by other factors. However, the miR-191
expressions in both the HCC cell lines and clinical HCC samples
were correlated with the DNA methylation status, and the demethyla-
tion agent induced HCC cell line demethylation at the hsa-miR-191
locus, resulting in the up-regulation of hsa-miR-191 expression.
Therefore, we concluded that the difference in DNA methylation sta-
tus in normal tissue, HCC cell lines, and clinical HCC samples is an
important mechanism underlying the differences in miR-191 expres-
sion in these samples.
Some miRNAs can induce an epithelial-to-mesenchymal transition
or mesenchymal-to-epithelial transition [21,22]. One of these, hsa-
miR-191, is an important miRNA that has been the focus of extensive
research. Some toxins (5-FU, dioxin and cigarette smoke, for example)
cause miR-191 deregulation [23–25]. In oncology research, increased
miR-191 expression has been reported in malignant melanoma, acute
myeloid leukemia, breast cancer, ovarian cancer, and colorectal cancer;
this high expression may be associated with poor prognosis [26–33].
High hsa-miR-191 expression has also been reported in HCC [24]. In
this study, we confirmed that miR-191 expression is associated with
poor prognosis in HCC and that DNA methylation is the factor that
causes increased miR-191 expression in HCC.
In our study, we identified nine genes (TIMP3, AUTS2, LTBP1,
PLOD2, LIMCH1, NFIA, BASP1, PCSK9, and SORL1) as miR-
191 candidate target genes from their baseline expression levels in
the normal tissue and HCC cell lines. TIMP3 plays a functional role
in the lysophosphatidic acid (LPA)–induced invasion [34], andmiR-21/
miR-221 and 222 can also regulate TIMP3 expression [35,36]. LTBP1
has been shown to regulate transforming growth factor-β activation and
regulate cancer metastasis and extracellular matrix accumulation
[37,38].PLOD2 has been reported to be a telopeptide lysyl hydroxylase,
which is an important enzyme in fibrosis [39]. NFIA can regulate cell
differentiation [40,41], and increased expression of NFIA is associated
with improved survival [42]. BASP1 is a weakly expressed gene in HCC
[43] that has been identified as a tumor suppressor [44] and a regulator
of differentiation [45]. PCSK9 is involved in lipid metabolism [46].
LIMCH1 and SORL1 are involved in metal ion transport/binding
[47,48]. AUTS2 has been identified in the regulation of alcohol
consumption. Thus, five of these nine genes are involved in oncology
research and are mainly associated with metastasis and differentiation;
these genes may also be involved in miR-191 function in hepatic car-
cinogenesis. The other genes may be associated with metabolism or
metal ion transport/binding, or they may be involved in miR-191 func-
tion in normal liver tissue.
In conclusion, our results suggest that DNA hypomethylation can
cause increased hsa-miR-191 expression in HCC cells and HCC tis-
sues and that this high expression is associated with poor prognosis.
Overexpression of hsa-miR-191 induced the SMMC-7721 cell line
to develop mesenchymal-like cell features (e.g., reduced cell-cell con-
tract, the appearance of long and thin processes, and increased cell
migration and invasion). hsa-miR-191 exerts these functions by tar-
geting nine genes. These findings may facilitate developing potential
HCC therapeutics.
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Figure W1. miR-191 target sequence.
